{"id":"NCT02053363","sponsor":"Washington University School of Medicine","briefTitle":"Tranexamic Acid Dosing in Adult Spinal Deformity Surgery","officialTitle":"Low Versus High Dose Tranexamic Acid in Adult Spinal Deformity Surgery: A Randomized, Blinded, Controlled Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2014-03","primaryCompletion":"2020-06-26","completion":"2020-06-26","firstPosted":"2014-02-03","resultsPosted":"2022-06-08","lastUpdate":"2022-06-08"},"enrollment":64,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Adult Spinal Deformity"],"interventions":[{"type":"DRUG","name":"Tranexamic Acid (Cyklokapron)","otherNames":[]}],"arms":[{"label":"High Dose/Study Group","type":"EXPERIMENTAL"},{"label":"Standard of Care/Control","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate two dosing protocols for tranexamic acid (TXA), an anti-fibrinolytic used to decrease blood loss in adult patients undergoing complex, reconstructive spinal fusion surgeries.","primaryOutcome":{"measure":"Blood Loss","timeFrame":"This outcome is measured during surgery, from exposure to wound closure, approximately 8 hours.","effectByArm":[{"arm":"High Dose/Study Group","deltaMin":2046,"sd":1104},{"arm":"Standard of Care/Control","deltaMin":1596,"sd":933}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20081519","15127250","17873821","19730217","19011538","18978408","11429344","15791100","17873823","19305284","21364458","35751772"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":25},"commonTop":["Infection","Delirium","Fracture"]}}